Ligand Reports Fourth Quarter and Full Year 2018 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. SPCX
3. MU
4. SPY
5. ACN
6. IBM
7. PRIM
8. PFE
9. TSLA
10. DPZ

Go back to Ligand Reports Fourth Quarter and Full Year 2018 Financial Results
LIGAND PHARMA (NASDAQ: LGND) Delayed: 271.01 +8.84 (3.37%)
Previous Close $262.17    52 Week High $139.79 
Open $259.35    52 Week Low $82.07 
Day High $272.50    P/E 630.26 
Day Low $258.00    EPS $0.43 
Volume 1,287,167